The Clinical Problem Solvers

DECEMBER 27, 2021

[link] CPSolvers team members Rafael Medina and Simone Vais take a moment to reflect on what is going on in the world of medicine focusing on vaccine uptake with two incredible experts on the matter about what their experiences have been. All three are vaccinated against COVID and 2 of 3 have had boosters.

Vaccination 52

Vaccination DO Family Medicine Internal Medicine 52

The Clinical Problem Solvers

MAY 2, 2022

Ebi found that the belief in genetic differences as an explanation for racial health disparities was associated with use of race-based clinical practices. Additionally, the belief that social inequalities explained racial health disparities was not associated with race-based practice. “Our December 17, 2020. February 23, 2021.

Healthcare 52

Healthcare Utilities Hospital Internal Medicine 52

FDA Law Blog

SEPTEMBER 10, 2023

An interesting addition in the final guidance is that it explains that the topics discussed “apply to any type of RWD, including data on products used in clinical practice under an emergency use authorization (EUA).” For obvious reasons, EUAs have been more prominent in recent years than they had been previously.

Provider 108

Provider Patient-Centered Clinic Patients 108

GeriPal

DECEMBER 1, 2023

I haven’t yet seen those clinical trials with beta-amyloid in asymptomatic individuals to allow me to reach that conclusion. Lon: Let me add to that with a bit of a disclosure, and that is we are NIA funded to develop amyloid vaccines, and I do that and I endorse that. I’ll stop there.

IT 117

IT Clinic Illness Hypertension 117

PEMBlog

JANUARY 17, 2024

Camargo, Clinical Trial: Comparative Effectiveness of Cephalexin Plus Trimethoprim-Sulfamethoxazole Versus Cephalexin Alone for Treatment of Uncomplicated Cellulitis: A Randomized Controlled Trial, Clinical Infectious Diseases, Volume 56, Issue 12, 15 June 2013, Pages 1754–1762, [link] Liu C, Bayer A, Cosgrove SE, et al.

IT 59

IT Patients Diagnosis Clinic 59